Document:

Management Continuity Agreement

 Exhibit 10.1 
 MANAGEMENT CONTINUITY AGREEMENT 
 THIS AGREEMENT
dated as of this 7th day of February 2012 between David S.
Burnett (the “Executive”) and EnPro Industries, Inc., a North Carolina corporation (the “Company”). 

WHEREAS, the Company considers it essential to the best interests of its shareholders to foster the continuous employment of key
management personnel in the event there is, or is threatened, a change in control of the Company; and 
 WHEREAS, the
Company recognizes that the uncertainty and questions which may arise among key management in connection with the possibility of a change in control may result in the departure or distraction of key management personnel to the detriment of the
Company and its shareholders; and 
 WHEREAS, the Company desires to provide certain protection to Executive in the event
of a change in control of the Company as set forth in this Agreement in order to induce Executive to remain in the employ of the Company notwithstanding any risks and uncertainties created by the possibility of a change in control of the Company;

 WITNESSETH: 
 NOW, THEREFORE, in consideration of the foregoing and the mutual promises herein contained, the parties agree as follows: 
 1. Term. The “Term” of this Agreement shall mean the period commencing on the date hereof and ending twenty-four (24) months after such date; provided, however, that
commencing on the date one year after the date hereof, and on each annual anniversary of such date (such date and each annual anniversary thereof shall be hereinafter referred to as the “Renewal Date”), the Term shall be automatically
extended so as to terminate twenty-four (24) months from such Renewal Date, unless at least sixty (60) days prior to the Renewal Date the Company shall give notice to the Executive that the Term shall not be so extended. 

2. Period of Employment. Executive’s “Period of Employment” shall commence on the date on which a Change in
Control occurs during the Term and shall end on the date that is twenty-four (24) months after the date on which such Change in Control occurs (subject to the provisions of Section 20 below pursuant to which the Period of Employment may be
deemed to have commenced prior to the date of a Change in Control in certain circumstances). 
 3. Certain
Definitions. For purposes of this Agreement: 
 “Board” shall mean the Board of Directors of
the Company. 
 “Cause” shall mean Executive’s termination of employment with the Company due to
(A) the willful and continued failure by Executive to substantially perform Executive’s duties with the Company, which failure causes material and demonstrable injury to the Company (other than any such failure resulting from
Executive’s incapacity due to physical or mental illness), after a demand for substantial performance is delivered 

 
to Executive by the Board which specifically identifies the manner in which the Board believes that Executive has not substantially performed Executive’s duties, and after Executive has been
given a period (hereinafter known as the “Cure Period”) of at least thirty (30) days to correct Executive’s performance, or (B) the willful engaging by Executive in other gross misconduct materially and demonstrably
injurious to the Company. For purposes hereof, no act, or failure to act, on Executive’s part shall be considered “willful” unless conclusively demonstrated to have been done, or omitted to be done, by Executive not in good faith and
without reasonable belief that Executive’s action or omission was in the best interests of the Company. Notwithstanding the foregoing, Executive shall not be deemed to have been terminated for Cause unless and until there shall have been
delivered to Executive a Notice of Termination which shall include a copy of a resolution duly adopted by the affirmative vote of not less than three-quarters of the entire membership of the Board at a meeting of the Board called and held for the
purpose (after reasonable notice to Executive and an opportunity for Executive, together with Executive’s counsel, to be heard before the Board), finding that in the good faith opinion of the Board Executive was guilty of conduct set forth
above in clause (A) (including the expiration of the Cure Period without the correction of Executive’s performance) or clause (B) above and specifying the particulars thereof in detail. 

“Change in Control” shall mean: 

(i) The acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”)), of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 20% or more of either (A) the then outstanding shares of common stock
of the Company (the “Outstanding Company Common Stock”) or (B) the combined voting power of the then outstanding voting securities of the Company entitled to vote generally in the election of directors (the “Outstanding Company
Voting Securities”); provided, however, that the following acquisitions shall not constitute a Change in Control: (A) any acquisition directly from the Company (other than by exercise of a conversion privilege), (B) any acquisition by
the Company or any of its subsidiaries, (C) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any of its subsidiaries or (D) any acquisition by any company with respect to which,
following such acquisition, more than 70% of, respectively, the then outstanding shares of common stock of such company and the combined voting power of the then outstanding voting securities of such company entitled to vote generally in the
election of directors is then beneficially owned, directly or indirectly, by all or substantially all of the individuals and entities who were the beneficial owners, respectively, of the Outstanding Company Common Stock and Outstanding Company
Voting Securities immediately prior to such acquisition in substantially the same proportions as their ownership, solely in their capacity as shareholders of the Company, immediately prior to such acquisition, of the Outstanding Company Common Stock
and Outstanding Company Voting Securities, as the case may be; or (ii) individuals who, as of the Distribution Date (as such term is defined in the Distribution Agreement among Goodrich Corporation, EnPro Industries, Inc. and Coltec Industries
Inc.), constitute the Board (the “Incumbent Board”) cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the Distribution Date whose election, or
nomination for election by the Company’s shareholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such

  
 2 

 
individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of either an actual or threatened
election contest; or (iii) consummation of a reorganization, merger or consolidation, in each case, with respect to which all or substantially all of the individuals and entities who were the beneficial owners, respectively, of the Outstanding
Company Common Stock and Outstanding Company Voting Securities immediately prior to such reorganization, merger or consolidation, do not, following such reorganization, merger or consolidation, beneficially own, directly or indirectly, solely in
their capacity as shareholders of the Company, more than 70% of, respectively, the then outstanding shares of common stock and the combined voting power of the then outstanding voting securities entitled to vote generally in the election of
directors, as the case may be, of the company resulting from such reorganization, merger or consolidation in substantially the same proportions as their ownership, immediately prior to such reorganization, merger or consolidation of the Outstanding
Company Common Stock and Outstanding Company Voting Securities, as the case may be; or (iv) consummation of (A) a complete liquidation or dissolution of the Company or (B) a sale or other disposition of all or substantially all of the
assets of the Company, other than to a company, with respect to which following such sale or other disposition, more than 70% of, respectively, the then outstanding shares of common stock of such company and the combined voting power of the then
outstanding voting securities of such company entitled to vote generally in the election of directors is then beneficially owned, directly or indirectly, by all or substantially all of the individuals and entities, solely in their capacity as
shareholders of the Company, who were the beneficial owners, respectively, of the Outstanding Company Common Stock and Outstanding Company Voting Securities immediately prior to such sale or other disposition in substantially the same proportion as
their ownership, immediately prior to such sale or other disposition, of the Outstanding Company Common Stock and Outstanding Company Voting Securities, as the case may be. 
 “Date of Termination” is as defined in Section 8 below. 

“Good Reason” shall mean: 
 (i) without Executive’s express written consent, (A) the assignment to Executive of any new duties or responsibilities substantially inconsistent in character with Executive’s duties and
responsibilities within the Company immediately prior to a Change in Control, (B) any substantial adverse change in Executive’s duties and responsibilities as in effect immediately prior to a Change in Control, including, but not limited
to, a reduction in duties or responsibilities which occurs because the Company is no longer an independent publicly-held entity, (C) any removal of Executive from or any failure to re-elect Executive to any director position of the Company,
(D) a change in the annual or long term incentive plan in which Executive currently participates such that Executive’s opportunity to earn incentive compensation is impaired, (E) a material reduction in the aggregate value of Company
perquisites made available to Executive, (F) an elimination or material impairment of Executive’s ability to participate in retirement plans comparable to those in which Executive currently participates, (G) any substantial increase
in Executive’s obligation to travel on the Company’s business over Executive’s present business travel obligations, or (H) an elimination or material impairment of Executive’s ability to receive stock options with values
comparable to those Executive was granted within the one year period preceding the commencement of the Period of Employment; (ii) the failure of the Company to comply with any other of its obligations

  
 3 

 
under Section 4 herein; (iii) the relocation of the offices of the Company at which Executive was employed immediately prior to the Change in Control to a location which is more than
fifty (50) miles from such prior location, or the failure of the Company to (A) pay or reimburse Executive, in accordance with the Company’s relocation policy for its employees in existence immediately prior to a Change in Control,
for all reasonable costs and expenses; plus “gross ups” referred to in such policy incurred by Executive relating to a change of Executive’s principal residence in connection with any relocation of the Company’s offices to which
Executive consents, and (B) indemnify Executive against any loss (defined as the difference between the actual sale price of such residence and the higher of (1) Executive’s aggregate investment in such residence or (2) the fair
market value of such residence as determined by the relocation management organization used by the Company immediately prior to the Change in Control (or other real estate appraiser designated by Executive and reasonably satisfactory to the
Company)) realized in the sale of Executive’s principal residence in connection with any such change of residence; (iv) the failure of the Company to obtain the assumption of and the agreement to perform this Agreement by any successor as
contemplated in Section 11 hereof; or (v) any purported termination of Executive’s employment during the Period of Employment which is not effected pursuant to a Notice of Termination satisfying the requirements of Section 7
hereof. 
 “Incapacity Discharge” means Executive’s termination of employment with the Company if,
as a result of Executive’s incapacity due to physical or mental illness, Executive shall have been absent from Executive’s duties with the Company on a full-time basis for one-hundred twenty (120) consecutive business days, and within
thirty (30) days after a written Notice of Termination is given, Executive shall not have returned to the full-time performance of Executive’s duties. 
 “Mandatory Retirement Date” shall mean the compulsory retirement date, if any, established by the Company for those executives of the Company who, by reason of their positions and the size of
their nonforfeitable annual retirement benefits under the Company’s pension, profit-sharing, and deferred compensation plans, are exempt from, the provisions of the Age Discrimination in Employment Act, 29 U.S.C. Sections 621, et seq., which
date shall not in any event be earlier for any executive than the last day of the month in which such Executive reaches age 65. 
 “Notice of Termination” is as defined in Section 7 below. 
 “Payment Period” shall mean twenty-four (24) months, provided that the Payment Period shall not exceed the number of whole calendar months between the Executive’s Date of Termination
and Mandatory Retirement Date (if applicable). 
 4. Compensation During Period of Employment. For so long during
Executive’s Period of Employment as Executive is an employee of the Company, the Company shall be obligated to compensate Executive as follows: 
 (a) Executive shall continue to receive Executive’s full base salary at the rate in effect immediately prior to the Change in Control. Executive’s base salary shall be increased annually, with
each such increase due on the anniversary date of Executive’s most recent previous increase. Each such increase shall be no less than an amount which 

  
 4 

 
at least equals on a percentage basis the mean of the annualized percentage increases in base salary for all elected officers of the Company during the two full calendar years immediately
preceding the Change in Control. 
 (b) Executive shall continue to participate in all benefit and compensation
plans (including but not limited to the Equity Compensation Plan, Long-Term Incentive Program, Performance Share Deferred Compensation Plan, Annual Performance Plan, Executive Life Insurance Program, Deferred Compensation Plan, 401(K) plan, savings
plan, flexible benefits plan, life insurance plan, health and accident plan or disability plan) in which Executive was participating immediately prior to the Change in Control, or in plans providing substantially similar benefits, in either case
upon terms and conditions and at levels at least as favorable as those provided to Executive under the plans in which Executive was participating immediately prior to the Change in Control; 

(c) Executive shall continue to receive all fringe benefits, perquisites, and similar arrangements which Executive was
entitled to receive immediately prior to the Change in Control; and 
 (d) Executive shall continue to receive
annually the number of paid vacation days and holidays Executive was entitled to receive immediately prior to the Change in Control. 
 5. Compensation Upon Termination of Employment. The following provisions set forth the benefits that may become payable to Executive upon termination of employment with the Company during
the Period of Employment in accordance with, and subject to, the provisions of Section 6 below: 
 (a) By
not later than the fifth business day following the Date of Termination, the Company shall pay Executive in a lump sum an amount equal to the sum of the following: 

(i) any base salary that is earned but unpaid as of the Date of Termination; 

(ii) a pro rata portion of the “target incentive amount” under the Annual Performance Plan for the calendar year
in which the Date of Termination occurs (based on the number of calendar days in such calendar year completed through the Date of Termination); and 
 (iii) a pro rata portion of the “calculated market value” of the phantom Performance Shares, if any, awarded to Executive under the Company’s Long-Term Incentive Program (the
“LTIP”) for each Plan Cycle under the LTIP that has not been completed as of the Date of Termination, determined as follows: 
 (A) The performance for each such Plan Cycle under the applicable LTIP award agreement shall be determined based on (x) for any completed calendar year of the Plan Cycle as of the Date of
Termination, actual performance for the calendar year, (y) for the calendar year in which the Date of Termination occurs if at least one calendar quarter has been completed during such calendar year, the greater of target

  
 5 

 
performance for the calendar year or actual performance for the completed calendar quarter(s) for the calendar year annualized for the year, and (z) for any other calendar years of the Plan
Cycle, target performance for the calendar year. 
 (B) The number of phantom Performance Shares for each such
Plan Cycle shall be adjusted in accordance with the formula set forth in the applicable LTIP award agreement based on the performance for the Plan Cycle determined under paragraph (A) above. 

(C) The pro rata portion of the “calculated market value” of the number of phantom Performance Shares adjusted
in accordance with paragraph (B) above shall be based on the number of calendar days in the Plan Cycle completed through the Date of Termination. 
 Section 5(c) below sets for the method for determining the “target incentive amount” under the Annual Performance Plan and the “calculated market value” of phantom Performance
Shares under the LTIP. Any amounts payable under Sections 5(a)(ii) or (iii) above shall be offset dollar-for-dollar by any pro rata payments otherwise provided for under the Annual Performance Plan or the LTIP. 

(b) In lieu of any salary payments that Executive would have received if he had continued in the employment of the Company
during the Payment Period, the Company shall pay to Executive in a lump sum, by not later than the fifth business day following the Date of Termination, an amount equal to one-twelfth of Executive’s annualized base salary in effect immediately
prior to the Date of Termination, multiplied by the number of months in the Payment Period. 
 (c) By not later
than the fifth day following the Date of Termination, the Company shall pay Executive in a lump sum an amount equal to the sum of: 
 (i) under the Annual Performance Plan (and in lieu of any further awards under the Annual Performance Plan that Executive would have received if he had continued in the employment of the Company during
the Payment Period), the number of months in the Payment Period multiplied by the greatest of one-twelfth of: (A) the amount most recently paid to Executive for a full calendar year; (B) Executive’s “target incentive amount”
for the calendar year in which his Date of Termination occurs; or (C) Executive’s “target incentive amount” in effect prior to the Change in Control for the calendar year in which the Change in Control occurs; plus, if
applicable, 
 (ii) under the LTIP (and in lieu of any further grants under the LTIP that Executive would have
received if he had continued in the employment of the Company during the Payment Period), sixteen (16) multiplied by the greatest of: (A) with respect to the most recently completed Plan Cycle as of the Date of Termination, one-twelfth of
the “calculated market value” of the Performance Shares actually awarded Executive (including the value of any Performance Shares Executive may have elected to defer under the Performance Share Deferred Compensation Program); (B) with
respect to the most recently 

  
 6 

 
commenced Plan Cycle under the LTIP (if Executive is a participant in such Plan Cycle) prior to Executive’s Date of Termination, one-twelfth of the “calculated market value” of the
phantom Performance Shares, if any, awarded to Executive; or (C) with respect to the most recently commenced Plan Cycle prior to the date of the occurrence of the Change in Control, one-twelfth of the “calculated market value” of the
phantom Performance Shares, if any, awarded to Executive. 
 For purposes of this Section 5,
Executive’s “target incentive amount” under the Annual Performance Plan for a given calendar year (i.e., the calendar year in which the Date of Termination occurs or the Change in Control occurs, as applicable) is determined by
multiplying (i) Executive’s annualized total gross base salary for the calendar year by (ii) the incentive target percentage which is applicable to Executive’s incentive category under the Annual Performance Plan for the calendar
year. For purposes of this Section 5, the “calculated market value” of each Performance Share actually awarded upon completion of a Plan Cycle, Performance Share deferred under the Performance Share Deferred Compensation Program or
phantom Performance Share granted under the LTIP shall be the mean of the high and low prices of the Company’s common stock on the relevant date as reported on the New York Stock Exchange Composite Transactions listing (or similar report), or,
if no sale was made on such date, then on the next preceding day on which a sale was made multiplied by the number of shares involved in the calculation. The relevant date for Section 5(a)(iii) and clauses 5(c)(ii)(B) and 5(c)(ii)(C) is the
date upon which the Compensation Committee (“Committee”) of the Board of Directors awarded the phantom Performance Shares in question; for clause 5(c)(ii)(A) the relevant date is the date on which the Committee made a determination of
attainment of financial objectives and awarded Performance Shares (including any Performance Shares Executive may have elected to defer under the Performance Share Deferred Compensation Program). 

Any payments received pursuant to Sections 5(c)(i) or (ii) above shall be in addition to, and not in lieu of, any
payments required to be made to Executive as the result of the happening of an event that would constitute a change in control pursuant to the provisions of the Annual Performance Plan or LTIP, as applicable. 

(d) By not later than the fifth day following the Date of Termination, the Company shall pay Executive in a lump sum an
amount equal to the sum of: 
 (i) If Executive is under age 55, or over the age of 55 but not eligible to
retire, at the Date of Termination the present value of all health and welfare benefits the Executive would have been entitled to had the Executive continued as an employee of the Company during the Payment Period and been entitled to or
participated in the same health and welfare benefits during the Payment Period as immediately prior to the Date of Termination plus an amount in cash equal to the amount necessary to cause the amount of the aggregate after-tax lump sum payment the
Executive receives pursuant to this provision to be equal to the aggregate after-tax value of the benefits which Executive would have received if Executive continued to receive such benefits as an employee; or 

  
 7 

 (ii) If Executive is age 55 or over and eligible to retire on the Date of
Termination, the present value of the health and welfare benefits to which Executive would have been entitled under the Company’s general retirement policies if Executive retired on the Date of Termination with the Company paying that
percentage of the premium cost of the plans which it would have paid under the terms of the plans in effect immediately prior to the Change of Control with respect to individuals who retire at age 65, regardless of Executive’s actual age on the
Termination Date, provided such lump sum value would be at least equal to the lump sum value of the benefits which would have been payable if Executive had been eligible to retire and had retired immediately prior to the Change in Control.

 (e) By not later than the fifth day following the Date of Termination, the Company shall pay Executive in a
lump sum an amount equal to the sum of the present value of the fringe benefit programs, perquisites (if any), and similar arrangements the Executive would have been entitled to receive had the Executive continued in employment with the Company for
the Payment Period and been entitled to or participated in the same such benefits during the Payment Period as immediately prior to the Date of Termination. In addition and notwithstanding any provision of the Company’s 2002 Equity Compensation
Plan (or any comparable equity award plan of the Company) or any applicable award agreement thereunder to the contrary, Executive may exercise any of Executive’s stock options that are vested as of Executive’s Date of Termination at any
time during the Payment Period (but not exceeding the original expiration date of the options). 
 (f) The
Company shall, in addition to the benefits to which Executive is entitled under the retirement plans or programs sponsored by the Company or its affiliates in which Executive participates (including without limitation any Supplemental Executive
Retirement Plan in which Executive participates, if applicable), pay Executive in a lump sum in cash by no later than the fifth day following the Date of Termination an amount equal to the actuarial equivalent of the retirement pension to which
Executive would have been entitled under the terms of such retirement plans or programs had Executive accumulated additional years of continuous service under such plans equal in length to Executive’s Payment Period. The length of the Payment
Period will be added to total years of continuous service for determining vesting, the amount of benefit accrual, to the age which Executive will be considered to be for the purposes of determining eligibility for normal or early retirement
calculations and the age used for determining the amount of any actuarial reduction. For the purposes of calculating the additional benefit accrual under this paragraph, the amount of compensation Executive will be deemed to have received during
each month of Executive’s Payment Period shall be equal to the sum of Executive’s annual base salary prorated on a monthly basis as provided for under Section 4(a) immediately prior to the Date of Termination (including salary
increases), plus under the Company’s Annual Performance Plan the greatest of one-twelfth of: 
 (i) the
amount most recently paid to Executive for a full calendar year, 
 (ii) Executive’s “target incentive
amount” for the calendar year in which Executive’s Date of Termination occurs, or 

  
 8 

 (iii) Executive’s “target incentive amount” in effect prior
to the Change in Control for the calendar year in which the Change in Control occurs. Attached as Exhibit 1 is an illustration, not intending to be exhaustive, of examples of how inclusion of the Payment Period may affect the calculation of
Executive’s retirement benefit. 
 (g) In no event shall any amount payable to Executive described in this
Section 5 be considered compensation or earnings under any pension, savings or other retirement plan of the Company. 
 6.
Termination. 
 (a) Termination Without Compensation. If Executive’s employment is
terminated for any of the following reasons, Executive shall not be entitled by virtue of this Agreement to any of the benefits provided in the foregoing Section 5: 

(i) If, prior to the commencement of the Period of Employment, Executive’s employment with the Company is terminated
at any time for any reason, including without limitation due to (A) Executive’s death, (B) an Incapacity Discharge, (C) a termination initiated by the Company with or without Cause or (D) resignation, retirement or other
termination initiated by Executive with or without Good Reason, subject, however, to the provisions of Section 20 below. 
 (ii) If Executive’s employment with the Company is terminated during the Period of Employment with Cause. 
 (iii) If Executive resigns, retires or otherwise voluntarily terminates employment with the Company during the Period of Employment without Good Reason. 

(b) Termination with Compensation. If Executive’s employment is terminated for any of the following reasons,
Executive shall be entitled by virtue of this Agreement to the benefits provided in the foregoing Section 5 as follows: 
 (i) If, during the Period of Employment, the Company discharges Executive other than for Cause, Executive shall receive all of the benefits and payments provided in Section 5. 

(ii) Executive may terminate his employment with the Company at any time during the Period of Employment for Good Reason
(“Good Reason Termination”) and shall receive all of the benefits and payments provided in Section 5. 
 (iii) If, during the Period of Employment, Executive either (A) retires from employment with the Company or (B) if the Company discharges Executive due to an Incapacity Discharge, in either case
while Executive has cause to terminate his employment as a Good Reason Termination (whether or not Executive has provided Notice of Termination to the Company pursuant to Section 7), Executive shall receive all of the benefits and payments
provided in Section 5. 

  
 9 

 (iv) If Executive dies while employed by the Company during the Period of
Employment while having cause to terminate his employment as a Good Reason Termination (whether or not Executive has provided Notice of Termination to the Company pursuant to Section 7), Executive’s beneficiary or beneficiaries named on
Exhibit 2 to this Agreement (or Executive’s estate if he has not named a beneficiary) shall be entitled to receive those payments provided under Sections 5(a), 5(b) and 5(c) of this Agreement in addition to any benefits that such beneficiaries
would be entitled under any other plan, program or policy of the Company as a result of Executive’s employment with the Company. 
 (v) Executive may become eligible for the benefits and payments under Section 5 for termination of employment prior to a Change in Control in accordance with, and subject to, the provisions of
Section 20 below. 
 7. Notice of Termination. Any termination of Executive’s employment by the Company
or any termination by Executive as a Good Reason Termination shall be communicated by written notice to the other party hereto. For purposes of this Agreement, such notice shall be referred to as a “Notice of Termination.” Such notice
shall, to the extent applicable, set forth the specific reason for termination, and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of Executive’s employment under the provision so
indicated. 
 8. Date of Termination. “Date of Termination” shall mean: 

(a) If Executive terminates Executive’s employment as a Good Reason Termination, the date specified in the Notice of
Termination, but in no event more than sixty (60) days after Notice of Termination is given. 
 (b) If
Executive’s employment is terminated with Cause, the date on which a Notice of Termination is given, except that the Date of Termination shall not be any date prior to the date on which the Cure Period expires without the correction of
Executive’s performance (if applicable). 
 (c) If Executive’s employment pursuant to this Agreement is
terminated following absence due to physical incapacity as an Incapacity Discharge, then the Date of Termination shall be thirty (30) days after Notice of Termination is given (provided that Executive shall not have returned to the performance
of Executive’s duties on a full-time basis during such thirty (30) day period). 
 (d) A termination of
employment by either the Company or by Executive shall not affect any rights Executive or Executive’s surviving spouse or beneficiaries may have pursuant to any other agreement or plan of the Company providing benefits to Executive, except as
provided in such agreement or plan. 

  
 10 

 9. Adjustments to Payments. 

(a) Anything in this Agreement to the contrary notwithstanding, in the event it shall be determined that any payment or
distribution by the Company to Executive or for Executive’s benefit (whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise (the “Payments”) would be subject to the excise tax
imposed by Section 4999 (or any successor provisions) of the Internal Revenue Code of 1986, as amended (the “Code”), or any interest or penalty is incurred by Executive with respect to such excise tax (such excise tax, together with
any such interest and penalties, is hereinafter collectively referred to as the “Excise Tax”), then the Payments shall be reduced (but not below zero) if and to the extent that such reduction would result in Executive retaining a larger
amount, on an after-tax basis (taking into account federal, state and local income taxes and the imposition of the Excise Tax), than if Executive received all of the Payments. The Company shall reduce or eliminate the Payments, by first reducing or
eliminating the portion of the Payments which are not payable in cash and then by reducing or eliminating cash payments, in each case in reverse order beginning with payments or benefits which are to be paid the farthest in time from the
determination. 
 (b) All determinations required to be made under this Section 9, including whether and
when an adjustment to any Payments is required and, if applicable, which Payments are to be so adjusted, shall be made by PricewaterhouseCoopers LLC (or their successors) (the “Accounting Firm”) which shall provide detailed supporting
calculations both to the Company and to Executive within fifteen (15) business days of the receipt of notice from Executive that there has been a Payment, or such earlier time as is requested by the Company. In the event that the Accounting
Firm is serving as accountant or auditor for the individual, entity or group effecting the Change in Control, Executive shall appoint another nationally recognized accounting firm to make the determinations required hereunder (which accounting firm
shall then be referred to as the Accounting Firm hereunder). All fees and expenses of the Accounting Firm shall be borne solely by the Company. If the Accounting Firm determines that no Excise Tax is payable by Executive, it shall furnish Executive
with a written opinion that failure to report the Excise Tax on Executive’s applicable federal income tax return would not result in the imposition of a negligence or similar penalty. Any determination by the Accounting Firm shall be binding
upon the Company and Executive. 
 10. No Obligation to Mitigate Damages, No Effect on Other Contractual Rights.
Executive shall not be required to refund the amount of any payment or employee benefit provided for or otherwise mitigate damages under this Agreement by seeking or accepting other employment or otherwise, nor shall the amount of any payment
required to be made under this Agreement be reduced by any compensation earned by Executive as the result of any employment by another employer after the date of termination of Executive’s employment with the Company, or otherwise. Upon receipt
of written notice from Executive that Executive has been reemployed by another company or entity on a full-time basis, benefits, fringe benefits and perquisites otherwise receivable by Executive pursuant to Sections 5(d) or 5(e) related to life,
health, disability and accident insurance plans and programs and other similar benefits, company cars, financial planning, country club memberships, and the like (but not incentive compensation, LTIP, pension plans or other similar plans and
programs) shall be reduced to the extent comparable benefits are made available to Executive at his new employment and any such benefits actually received by Executive shall be reported to the Company by Executive. 

  
 11 

 The provisions of the Agreement, and any payment or benefit provided for hereunder shall not
reduce any amount otherwise payable, or in any way diminish Executive’s existing rights, or rights which would occur solely as a result of the passage of time, under any other agreement, contract, plan or arrangement with the Company.

 11. Successors and Binding Agreement. 

(a) The Company shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise)
to all or substantially all of the business or assets of the Company, by agreement in form and substance satisfactory to Executive, to assume and agree to perform this Agreement. 

(b) This Agreement shall be binding upon the Company and any successor of or to the Company, including, without
limitation, any person acquiring directly or indirectly all or substantially all of the assets of the Company whether by merger, consolidation, sale or otherwise (and such successor shall thereafter be deemed the “Company” for the purposes
of this Agreement), but shall not otherwise be assignable by the Company. 
 (c) This Agreement shall inure to
the benefit of and be enforceable by Executive and Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. If Executive should die while any amounts would still be
payable to Executive pursuant to Sections 5 and 6 hereunder if Executive had continued to live, all such amounts, unless otherwise provided herein, shall be paid in accordance with the terms of this Agreement to Executive’s devisee, legatee, or
other designee or, if there be no such designee, to Executive’s estate. 
 12. Notices. For the purposes of
this Agreement, notices and all other communications provided for in the Agreement shall be in writing and shall be deemed to have been duly given when delivered or mailed by United States registered mail, return receipt requested, postage prepaid,
addressed to the respective addresses set forth on the first page of this Agreement, provided that all notices to the Company shall be directed to the attention of the Chief Executive Officer of the Company with a copy to the Secretary of the
Company, or to such other address as either party may have furnished to the other in writing, except that notices of change of address shall be effective only upon receipt. 
 13. Governing Law. The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the State of North Carolina, without giving effect to the
principles of conflict of laws of such State. 
 14. Miscellaneous. No provisions of this Agreement may be
modified, waived or discharged, and this Agreement may not be terminated before the end of the Term, unless such waiver, modification, discharge or termination is agreed to in a writing signed by Executive and the Company. No waiver by either party
hereto at any time of any breach by the other party hereto or compliance with, any condition or provision of this Agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same

  
 12 

 
or at any prior or subsequent time. No agreements or representations, oral or otherwise, express or implied, with respect to the subject matter hereof, have been made by either party which is not
set forth expressly in this Agreement. 
 15. Validity. The invalidity or unenforceability of any provisions of
this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, which shall remain in full force and effect. 
 16. Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original, but all of which together will constitute one and the same
agreement. 
 17. Withholding of Taxes. The Company may withhold from any amounts payable under this Agreement all
federal, state, city or other taxes as shall be required pursuant to any law or government regulation or ruling. 
 18.
Nonassignability. This Agreement is personal in nature and neither of the parties hereto shall, without the consent of the other, assign or transfer this Agreement or any rights or obligations hereunder, except as provided in
Section 11 above. Without limiting the foregoing, Executive’s right to receive payments hereunder shall not be assignable or transferable, whether by pledge, creation of a security interest or otherwise, other than by a transfer by
Executive’s will or by the laws of descent and distribution and in the event of any attempted assignment or transfer contrary to this Section 18 the Company shall have no liability to pay any amounts so attempted to be assigned or
transferred. 
 19. Legal Fees and Expenses. If a Change in Control shall have occurred, thereafter the Company
shall pay and be solely responsible for any and all attorneys’ and related fees and expenses incurred by Executive to successfully (in whole or in part and whether by modification of the Company’s position, agreement, compromise,
settlement, or administrative or judicial determination) enforce this Agreement or any provision hereof or as a result of the Company or any Shareholder of the Company contesting the validity or enforceability of this Agreement or any provision
hereof. To secure the foregoing obligation, the Company shall, within 90 days after being requested by Executive to do so, enter into a contract with an insurance company, open a letter of credit or establish an escrow in a form satisfactory to
Executive. Notwithstanding the provisions of this Section 19 to the contrary, in no event shall any payments made to Executive under this Section 19 be made for expenses incurred by Executive following the end of the second calendar year
following the calendar year in which Executive’s Date of Termination occurs, provided that the period during which reimbursement for such expenses may be made may extend to the end of the third calendar year in which Executive’s Date of
Termination occurs. 
 20. Employment Rights. Nothing expressed or implied in this Agreement shall create any
right or duty on Executive’s part or on the part of the Company to have Executive remain in the employment of the Company prior to the commencement of the Period of Employment; provided, however, that any termination or purported termination of
Executive’s employment by the Company without Cause, or termination of Executive’s employment by Executive under circumstances that would constitute Good Reason had a Change in Control occurred, in either case following the commencement of
any discussion with a third party, or the announcement by a third party of the commencement of, or the intention to commence a tender 

  
 13 

 
offer, or other intention to acquire all or a portion of the equity securities of the Company that ultimately results in a Change in Control shall be deemed to be a termination of
Executive’s employment after a Change in Control for purposes of (i) this Agreement and both the Period of Employment and the Payment Period shall be deemed to have begun on the day prior to such termination and (ii) the
Company’s Equity Compensation Plan as if the Change in Control had occurred on the day prior to such termination (resulting in the full vesting and extended exercisability of the Executive’s outstanding stock options under, and in
accordance with, the provisions of the Equity Compensation Plan). 
 21. Right of Setoff. There shall be no right
of setoff or counterclaim against, or delay in, any payment by the Company to Executive or Executive’s designated beneficiary or beneficiaries provided for in this Agreement in respect of any claim against Executive or any debt or obligation
owed by Executive, whether arising hereunder or otherwise. 
 22. Rights to Other Benefits. The existence of the
Agreement and Executive’s rights hereunder shall be in addition to, and not in lieu of, Executive’s rights under any other of the Company’s compensation and benefit plans and programs, and under any other contract or agreement between
Executive and the Company. 
 23. Prior Agreements. This Agreement supersedes and replaces any and all prior
agreements and understandings between the Company and the Executive with respect to the subject matter hereof. Any such prior agreements and understandings are no longer in force or effect. 

24. Compliance with Section 409A of the Internal Revenue Code. Any payments under this Agreement that are deemed to be
deferred compensation subject to the requirements of Section 409A (“Section 409A”) of the Internal Revenue Code of 1986, as amended, are intended to comply with the requirements of Section 409A. To this end and notwithstanding
any other provision of this Agreement to the contrary, if at the time of Executive’s termination of employment with the Company, (i) the Company’s securities are publicly traded on an established securities market; (ii) Executive
is a “specified employee” (as defined in Section 409A); and (iii) the deferral of the commencement of any payments or benefits otherwise payable pursuant to this Agreement as a result of such termination of employment is
necessary in order to prevent any accelerated or additional tax under Section 409A, then the Company will defer the commencement of such payments (without any reduction in amount ultimately paid or provided to Executive) that are not paid
within the short-term deferral rule under Section 409A (and any regulations thereunder) or within the “involuntary separation” exemption of Treasury Regulation § 1.409A-1(b)(9)(iii). Such deferral shall last until the date that
is six (6) months following Executive’s termination of employment with the Company (or the earliest date as is permitted under Section 409A). Any amounts the payment of which are so deferred shall be paid in a lump sum payment within
ten (10) days after the end of such deferral period. If Executive dies during the deferral period prior to the payment of any deferred amount, then the unpaid deferred amount shall be paid to the personal representative of Executive’s
estate within sixty (60) days after the date of Executive’s death. For purposes of Section 409A, the right to a series of installment payments under this Agreement shall be treated as a right to a series of separate payments.

  
 14 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the Effective
Date. 
  

			
	ENPRO INDUSTRIES, INC.
		
	By:    	 	/s/ Stephen E. Macadam
		 	Name: Stephen E. Macadam
		 	Title: President and Chief Executive Officer
		
		 	/s/ David S. Burnett
		 	David S. Burnett

  
 15 

 EXHIBIT 1 
 A. If as of Executive’s Date of Termination Executive’s years of continuous service under the applicable retirement plans for purposes of determining eligibility for normal or early retirement
plus the length of Executive’s Payment Period is at least 5, then 
 1. If as of Executive’s Date of
Termination Executive’s age plus the length of Executive’s Payment Period is at least 65, Executive’s retirement benefit under Section 5(f) will be calculated as a “normal retirement” benefit to which Executive would
have been entitled under the terms of the retirement plan in which Executive participates had Executive accumulated benefit service under the retirement plan that included the Payment Period; and 

2. If as of Executive’s Date of Termination Executive’s age plus the length of Executive’s Payment Period
is at least 55 but less than 65, Executive’s retirement benefit under Section 5(f) will be calculated as an “early retirement” benefit to which Executive would have been entitled under the terms of the retirement plan in which
Executive participates had Executive accumulated benefit service under the retirement plan that included the Payment Period. The actuarial reduction used shall be the actuarial reduction factor for early retirement, calculated to Executive’s
actual age plus the length of Executive’s Payment Period, at Executive’s Date of Termination. 
 B. If as of
Executive’s Date of Termination the sum of Executive’s years of continuous service under the applicable retirement plans for purposes of determining eligibility for normal or early retirement plus the length of Executive’s Payment
Period is less than 5, or Executive’s age plus the length of Executive’s Payment Period is less than 55, Executive’s retirement benefit under Section 5(f) will be calculated as a “deferred vested pension” to which
Executive would have been entitled under the terms of the retirement plans in which Executive participates had Executive accumulated benefit service under the retirement plan that included the Payment Period. The actuarial reduction used shall be
the actuarial reduction factor for a deferred vested pension, calculated to Executive’s actual age at Executive’s Date of Termination plus the length of Executive’s Payment Period. 

C. For purposes of Section 5(f), “actuarial equivalent” shall be determined using the same methods and assumptions as
those utilized under the Company’s retirement plans and programs immediately prior to the Change in Control. 

 EXHIBIT 2 
 BENEFICIARY DESIGNATION 
 I hereby designate the following person(s) as a
beneficiary for the purposes of Section 6(b)(iv) to the extent of the percentage interest listed next to their name: 
  

			
	 NAME
	 	 PERCENTAGE INTEREST

	
	 TOTAL (CANNOT EXCEED 100%)EX-10.6

 Exhibit 10.6 
 EXECUTION VERSION 
  

			
	 CREDIT SUISSE SECURITIES (USA) LLC

CREDIT SUISSE AG
 Eleven Madison Avenue
 New York, NY 10010
	 	 UBS SECURITIES LLC
 UBS LOAN FINANCE LLC
 299 Park Avenue

New York, New York 10171

 CONFIDENTIAL 
 January 20, 2012 
 TransDigm Group Incorporated 

The Tower at Erieview 
 1301 East 9th Street,
Suite 3710 
 Cleveland, OH 44114 
  

			
	Attention:	  	Greg Rufus
		  	Executive Vice President and
		  	Chief Financial Officer

 $500,000,000 Senior Secured Term Facility 

Commitment Letter 
 Ladies
and Gentlemen: 
 You have advised Credit Suisse AG (acting through such of its affiliates or branches as it deems appropriate,
“CS”), Credit Suisse Securities (USA) LLC (“CS Securities” and, together with CS and their respective affiliates, “Credit Suisse”), UBS Loan Finance LLC
(“UBSLF” and, together with CS, the “Initial Lenders”) and UBS Securities LLC (“UBS Securities” and, together with UBSLF and their respective affiliates,
“UBS”) (Credit Suisse and UBS are collectively referred to herein as “we” or “us”) that you intend to acquire (the “Acquisition”), through a newly formed
wholly owned subsidiary of the Borrower, all of the equity interests of AmSafe Global Holdings, Inc., a Delaware corporation (the “Company”) from BSR LLC, Greenbriar Equity Fund II, L.P. and related investors (collectively
referred to herein as the “Seller”) and to consummate the other Transactions (such term and each other capitalized term used but not defined herein having the meaning assigned to such term in the Summary of Principal Terms
and Conditions attached hereto as Exhibit A (the “Term Sheet”)). You have further advised us that, in connection therewith, the Borrower will obtain the senior secured term facility (the “Term
Facility”) described in the Term Sheet, in an aggregate principal amount of up to $500,000,000. 

 1. Commitments. 

In connection with the foregoing, (a) CS is pleased to advise you of its commitment to provide 70% of the aggregate principal amount
of the Term Facility and (b) UBSLF is pleased to advise you of its commitment to provide 30% of the aggregate principal amount of the Term Facility, in each case upon the terms and subject to the conditions set forth or referred to in this
commitment letter (including the Term Sheet and other attachments hereto, this “Commitment Letter”). 

2. Titles and Roles. 
 You hereby appoint (a) CS Securities and UBS Securities to act, and CS Securities and UBS Securities hereby agree to act, as joint lead arrangers and joint bookrunners for the Term Facility (together
in such capacities, the “Arrangers”), and (b) CS to act, and CS hereby agrees to act, as sole administrative agent and sole collateral agent for the Term Facility, in each case upon the terms and subject to the
conditions set forth or referred to in this Commitment Letter. Each of CS Securities, UBS Securities and CS, in such capacities, will perform the duties and exercise the authority customarily performed and exercised by it in such roles. You agree
that no other titles will be awarded and no compensation (other than that expressly contemplated by this Commitment Letter and the Fee Letter referred to below) will be paid in connection with the Term Facility unless you and we shall so agree. It
is agreed that Credit Suisse will have “left” placement in any and all marketing materials or other documentation used in connection with the Term Facility. 
 3. Syndication. 
 We reserve the right, prior to and/or after the execution
of definitive documentation for the Term Facility, to syndicate all or a portion of the Initial Lenders’ commitments in respect of the Term Facility to a group of banks, financial institutions and other institutional lenders (together with the
Initial Lenders, the “Lenders”) identified by the Arrangers in consultation with you, and you agree to provide us with a period of at least 15 days following the launch of the general syndication of the Term Facility on the
date of the general meeting with prospective Lenders and immediately prior to the Closing Date to syndicate the Term Facility. We intend to commence syndication efforts promptly upon the execution of this Commitment Letter and the public
announcement of the Transactions, and you agree to actively assist us in completing a Successful Syndication (as defined in the Fee Letter). Such assistance shall include (a) your using commercially reasonable efforts to ensure that any
syndication efforts benefit from your existing lending and investment banking relationships and the existing lending and investment banking relationships of the Company and the Borrower, (b) direct contact between senior management,
representatives and advisors of you and the Borrower (and your using commercially reasonable efforts to cause direct contact between senior management, representatives and advisors of the Company) and the proposed Lenders, (c) assistance by you
and the Borrower (and your using commercially reasonable efforts to cause the assistance by the Company) in the preparation of a Confidential Information 

  
 2 

 
Memorandum for the Term Facility and other customary marketing materials and presentations to be used in connection with the syndication (collectively, “Information
Materials”), (d) your providing or causing to be provided a detailed business plan or projections of Holdings and its subsidiaries for the years 2012 through 2016, in form and substance reasonably satisfactory to the Arrangers (it
being understood that the projections received by the Arrangers on or prior to the date hereof are satisfactory), (e) your using commercially reasonable efforts to obtain a public corporate credit rating from Standard & Poor’s
Ratings Service (“S&P”) and a public corporate family rating from Moody’s Investors Service, Inc. (“Moody’s”), in each case in respect of Holdings, and public ratings for the Term
Facility from each of S&P and Moody’s at least 15 days prior to the Closing Date, and (f) the hosting, with the Arrangers, of one or more meetings of prospective Lenders at such times as may be reasonably agreed upon. Notwithstanding
the foregoing or anything else in this Commitment Letter or the Fee Letter to the contrary, neither the commencement nor completion of the syndication of the Term Facility, nor the obtaining of the ratings referred to above shall be a condition
precedent to the availability of the borrowings on the Closing Date. 
 You agree, at the request of any of the Arrangers, to
assist (and to use commercially reasonable efforts to cause the Company to assist) in the preparation of versions of the Information Materials consisting exclusively of information and documentation that is either (i) publicly available or of a
type that would be publicly available if the Company were a public reporting company or (ii) not material with respect to Holdings, the Borrower, the Company, the Seller or their respective subsidiaries or any of their respective securities for
purposes of foreign, United States Federal and state securities laws (all such Information Materials being “Public Lender Information”). Any information and documentation that is not Public Lender Information is referred to
herein as “Private Lender Information”. Before distribution of any Information Materials, you agree to execute and deliver to the Arrangers (i) a letter in which you authorize distribution of the Information Materials to
Lenders’ employees willing to receive Private Lender Information and (ii) a letter in which you authorize distribution of Information Materials containing solely Public Lender Information and represent that such Information Materials do
not contain any Private Lender Information, which letters shall in each case include a customary representation as to the accuracy of the Information Materials. You further agree that each document to be disseminated by any of the Arrangers to any
Lender in connection with the Term Facility will, at the request of any of the Arrangers, be identified by you as either (i) containing Private Lender Information or (ii) containing solely Public Lender Information. You acknowledge that
the following documents, if final drafts of which are provided to you before their intended distribution, contain solely Public Lender Information (unless you notify us prior to their intended distribution that any such document contains Private
Lender Information): (a) drafts and final definitive documentation with respect to the Term Facility; (b) administrative materials prepared by us for prospective Lenders (such as a lender meeting invitation, bank allocation, if any, and
funding and closing memoranda); (c) notification of changes in the terms of the Term Facility; and (d) other 

  
 3 

 
materials (excluding the Projections (as defined below)) intended for public Lenders after the initial distribution of Information Materials. 

The Arrangers will manage all aspects of any syndication in consultation with you, including decisions as to the selection of
institutions to be approached and when they will be approached, when their commitments will be accepted, which institutions will participate, the allocation of the commitments among the Lenders, any naming rights and the amount and distribution of
fees among the Lenders. To assist the Arrangers in their syndication efforts, you agree promptly to prepare and provide (and to use commercially reasonable efforts to cause the Company promptly to provide) to the Arrangers all customary information
with respect to Holdings, the Borrower, the Company and their respective subsidiaries, the Transactions and the other transactions contemplated hereby, including all financial information and projections (together with all other forward-looking
information, the “Projections”), as any of the Arrangers may reasonably request in connection with the syndication of the Term Facility. 
 4. Information. 
 You hereby represent and covenant (with respect to the
Seller, the Company and their respective subsidiaries, to the best of your knowledge) that (a) all information other than the Projections (the “Information”) that has been or will be made available to us by or on behalf
of you or any of your representatives is or will be, when furnished, complete and correct in all material respects when taken as a whole and does not or will not, when furnished, contain any untrue statement of a material fact or omit to state a
material fact necessary in order to make the statements contained therein not materially misleading in light of the circumstances under which such statements are made (giving effect to all supplements and updates thereto) and (b) the
Projections that have been or will be made available to us by or on behalf of you or any of your representatives have been or will be prepared in good faith based upon assumptions that are reasonable at the time made and at the time the related
Projections are made available to us (it being recognized that actual results during the period or periods covered by such Projections may differ from the projected results and that such differences may be material). You agree that if at any time
prior to the later of (i) the closing of the Term Facility and (ii) the completion of a Successful Syndication (as determined by the Arrangers) but in no event later than the date that is 90 days following the closing of the Term Facility,
any of the representations in the preceding sentence would be incorrect if the Information and Projections were being furnished, and such representations were being made, at such time, then you will promptly supplement the Information and the
Projections so that such representations will be correct in all material respects under those circumstances. In arranging and syndicating the Term Facility, we will be entitled to use and rely primarily on the Information and the Projections without
responsibility for independent verification thereof. 

  
 4 

 5. Fees. 
 As consideration for the Commitments hereunder, and our agreements to perform the services described herein, you agree to pay (or to cause the Borrower to pay) to us for our own accounts the fees set
forth in (a) this Commitment Letter and (b) the fee letter dated the date hereof and delivered herewith with respect to the Term Facility (the “Fee Letter”). 

6. Conditions Precedent. 
 Each Initial Lender’s commitment hereunder, and our agreements to perform the services described herein, are subject to (a) except as contemplated by the Merger Agreement, there not having
occurred any effect, event, change, occurrence, development or circumstance since December 31, 2011 that would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect (as defined in Exhibit C),
(b) our satisfaction that, prior to the later of (i) the closing of the Term Facility and (ii) the completion of a Successful Syndication (as determined by the Arrangers) but in no event later than the date that is 90 days following
the closing of the Term Facility, there shall be no other competing issues of debt securities or commercial bank or other competing credit facilities of Holdings, the Borrower, the Company or their respective subsidiaries being announced, offered,
placed or arranged (other than any such issues coordinated with the Arrangers), (c) the negotiation, execution and delivery of definitive documentation with respect to the Term Facility (the “Loan Documents”) consistent
with this Commitment Letter and the Fee Letter and otherwise mutually satisfactory to the parties hereto; provided that the requirements of the Loan Documents will be such so as not to cause the Borrower, by entering into the same, to be in
default of the 2010 Credit Agreement or the 2011 Credit Agreement (it being understood that this proviso shall not apply to any default resulting from failure to meet any required financial ratio under the 2010 Credit Agreement or the 2011 Credit
Agreement in connection with incurring the debt under the Term Facility), (d) your compliance with the terms of Section 3 of this Commitment Letter and the Fee Letter, (e) the payment in full of all fees, expenses and other amounts
due and payable to us under this Commitment Letter and the Fee Letter (which amounts may be offset against the proceeds of the Term Facility), and (f) the conditions set forth or referred to in the Term Sheet under the heading “Conditions
Precedent to Borrowing” and in Exhibit B. 
 Notwithstanding anything to the contrary in this Commitment Letter, the
Fee Letter, the Loan Documents or any other letter agreement or other undertaking concerning the financing of the transactions contemplated hereby, (a) the only representations relating to Holdings, the Company and their respective
subsidiaries, the accuracy of which shall be a condition to the availability of the Term Facility on the Closing Date, shall be (i) such of the representations made by the Seller or the Company in the Merger Agreement as are material to the
interests of the Lenders, but only to the extent that Holdings or the Borrower has the right to terminate its obligations under the Merger Agreement or decline to consummate the Acquisition as a result of a breach of

  
 5 

 
such representations in the Merger Agreement (the “Merger Agreement Representations”) and (ii) the Specified Representations (as defined below), and (b) the
terms of the Loan Documents shall be in a form such that they do not impair availability or funding of the Term Facility on the Closing Date if the conditions set forth in this Commitment Letter are satisfied (it being understood that, to the extent
(x) any guarantee to be provided by any subsidiary of the Company which is not a person incorporated or formed in the United States or the District of Columbia or (y) any collateral referred to in the Term Sheet is not or cannot be
provided or perfected on the Closing Date after your use of commercially reasonable efforts to do so (other than the grant and perfection of security interests in assets located in any state of the United States or the District of Columbia with
respect to which a lien may be perfected by the filing of a financing statement under the Uniform Commercial Code or a short-form security agreement with the United States Copyright Office or the United States Patent and Trademark Office or, in the
case of stock certificates of the Borrower and its domestic subsidiaries and intercompany notes of Holdings and its domestic subsidiaries, by possession of such collateral), then the provision or perfection, as the case may be, of any such guarantee
or collateral shall not constitute a condition precedent to the availability of the Term Facility on the Closing Date, but may instead be provided or perfected, as the case may be, after the Closing Date pursuant to arrangements to be mutually
agreed). For purposes hereof, “Specified Representations” means the representations and warranties referred to in the Term Sheet relating to corporate existence, power and authorization (as to the execution, delivery and
performance of the Loan Documents), due authorization, execution and delivery and enforceability of the Loan Documents, validity, priority (subject to permitted liens (to be defined in a manner consistent with the Existing Credit Agreements)) and
perfection of security interests in the Collateral (subject to the limitations set forth in the preceding sentence), solvency of Holdings and its subsidiaries on a consolidated basis after giving effect to the Transactions, no conflicts with laws,
charter documents, the Existing Credit Agreements and other material agreements, compliance with the PATRIOT Act, margin regulations, the Investment Company Act, laws applicable to sanctioned persons and the Foreign Corrupt Practices Act and status
of the Term Facility and guarantees thereof as “senior debt” and “designated senior debt” under the Existing Notes Documents (as defined in the 2011 Credit Agreement). This paragraph, and the provisions herein, shall be referred
to as the “Conditions Limitation Provision”. 
 7. Indemnification; Expenses. 

You agree (a) to indemnify and hold harmless each of us and each of our respective affiliates, partners, officers, directors,
employees, agents, advisors, controlling persons, members and successors and assigns (each, an “Indemnified Person”) from and against any and all losses, claims, damages, liabilities and expenses, joint or several, to which
any such Indemnified Person may become subject arising out of or in connection with this Commitment Letter, the Fee Letter, the Transactions, the Term Facility or any related transaction or any claim, litigation, investigation or proceeding relating
to any of the foregoing, regardless of whether any such Indemnified Person is a party thereto (and 

  
 6 

 
regardless of whether such matter is initiated by a third party or by Holdings, the Company or any of their respective affiliates or shareholders), and to reimburse each such Indemnified Person
upon demand for any reasonable legal or other reasonable out-of-pocket expenses incurred in connection with investigating or defending any of the foregoing; provided that the foregoing indemnity will not, as to any Indemnified Person, apply
to losses, claims, damages, liabilities or related expenses (i) to the extent they are found by a final, nonappealable judgment of a court of competent jurisdiction to arise from the willful misconduct, bad faith or gross negligence of such
Indemnified Person, (ii) to the extent they are found by a final, nonappealable judgment of a court of competent jurisdiction to arise from a material breach of the obligations of such Indemnified Person under this Commitment Letter, or
(iii) arising out of or in connection with any claim, litigation, investigation or proceeding that does not involve an act or omission of you, the Borrower or any of your affiliates (as found by a final, nonappealable judgment of a court of
competent jurisdiction) and that is brought by an Indemnified Person against any other Indemnified Person (other than any such Indemnified Person acting as an agent, arranger, bookrunner or similar role under the Term Facility) and (b) to
reimburse each of us from time to time, upon presentation of a reasonably detailed invoice, for all reasonable out-of-pocket expenses (including but not limited to the reasonable expenses of our due diligence investigation, consultants’ fees,
syndication expenses, travel expenses and fees, disbursements and other charges of a single counsel plus, to the extent necessary, one local counsel in each applicable jurisdiction, any special counsel and, in the case of a conflict of interest or
separate defenses available to Indemnified Persons that are different from those available to the other Indemnified Persons, one additional counsel per affected party), in each case, incurred in connection with the Term Facility and the preparation,
negotiation and enforcement of this Commitment Letter, the Fee Letter, the Loan Documents and any ancillary documents and security arrangements in connection therewith. Notwithstanding any other provision of this Commitment Letter, no Indemnified
Person shall be liable for any indirect, special, punitive or consequential damages in connection with its activities related to the Term Facility, this Commitment Letter or the Fee Letter. 

8. Sharing Information; Absence of Fiduciary Relationship; Affiliate Activities. 

You acknowledge that we and our respective affiliates may be providing debt financing, equity capital or other services (including
financial advisory services) to other companies in respect of which you may have conflicting interests regarding the transactions described herein or otherwise. We will not furnish confidential information obtained from you by virtue of the
transactions contemplated by this Commitment Letter or our other relationships with you to other companies. You also acknowledge that we do not have any obligation to use in connection with the transactions contemplated by this Commitment Letter, or
to furnish to you, confidential information obtained by us from other companies. 
 You further acknowledge and agree that
(a) no fiduciary, advisory or agency relationship between you and us is intended to be or has been created in respect of any of 

  
 7 

 
the transactions contemplated by this Commitment Letter, irrespective of whether we have advised or are advising you on other matters, (b) each of us, on the one hand, and you, on the other
hand, have an arm’s-length business relationship that does not directly or indirectly give rise to, nor do you rely on, any advisory or fiduciary duty on the part of any of us, (c) you are capable of evaluating and understanding, and you
understand and accept, the terms, risks and conditions of the transactions contemplated by this Commitment Letter, (d) you have been advised that each of us is engaged in a broad range of transactions that may involve interests that differ from
your interests and that none of us has any obligation to disclose such interests and transactions to you by virtue of any fiduciary, advisory or agency relationship, and (e) you waive, to the fullest extent permitted by law, any claims you may
have against any of us for breach of fiduciary duty or alleged breach of fiduciary duty in connection with this Commitment Letter, the Fee Letter, the Term Facility or any transactions contemplated hereby or thereby and agree that none of us shall
have any liability (whether direct or indirect) to you in respect of such a fiduciary duty claim or to any person asserting a fiduciary duty claim on behalf of or in right of you, including your stockholders, employees or creditors. Additionally,
you acknowledge and agree that none of us is advising you as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction (including, without limitation, with respect to any consents needed in connection with the transactions
contemplated hereby). You shall consult with your own advisors concerning such matters and shall be responsible for making your own independent investigation and appraisal of the transactions contemplated hereby (including, without limitation, with
respect to any consents needed in connection therewith), and we shall have no responsibility or liability to you with respect thereto. Any review by us of Holdings, the Borrower, the Company, the Transactions, the other transactions contemplated
hereby or other matters relating to such transactions will be performed solely for our benefit and shall not be made on behalf of you or any of your affiliates. 
 You further acknowledge that each of Credit Suisse and UBS is a full service securities firm engaged in securities trading and brokerage activities as well as providing investment banking and other
financial services. In the ordinary course of business, each of us may provide investment banking and other financial services to, and/or acquire, hold or sell, for its own accounts and the accounts of customers, equity, debt and other securities
and financial instruments (including bank loans and other obligations) of, you, the Borrower, the Company and other companies with which you, the Borrower or the Company may have commercial or other relationships. With respect to any securities
and/or financial instruments so held by us or any of our customers, all rights in respect of such securities and financial instruments, including any voting rights, will be exercised by the holder of the rights, in its sole discretion. 

9. Assignments; Amendments; Governing Law, Etc. 
 This Commitment Letter shall not be assignable by you without the prior written consent of each Initial Lender and each Arranger (and any attempted assignment without such consent shall be null and void),
is intended to be solely for the benefit of the parties 

  
 8 

 
hereto (and Indemnified Persons), and is not intended to confer any benefits upon, or create any rights in favor of, any person other than the parties hereto (and Indemnified Persons). Each of
the Initial Lenders may assign its commitment hereunder to one or more prospective Lenders, whereupon such Initial Lender shall be released from the portion of its commitment hereunder so assigned; provided that such Initial Lender shall
not be so released except (a) in the event that such assignee was approved by you in writing (such approval not to be unreasonably withheld or delayed) or (b) to the extent such assignee funds the portion of the commitment assigned to it
on the Closing Date. Any and all obligations of, and services to be provided by any of us hereunder (including, without limitation, each Initial Lender’s commitment) may be performed and any and all rights of any of us hereunder may be
exercised by or through any of our respective affiliates or branches; provided that no Initial Lender will be relieved of its obligations hereunder in the event its affiliates fail to perform any of such obligations or services. This
Commitment Letter may not be amended or any provision hereof waived or modified except by an instrument in writing signed by each Initial Lender, each Arranger and you. This Commitment Letter may be executed in any number of counterparts, each of
which shall be an original and all of which, when taken together, shall constitute one agreement. Delivery of an executed counterpart of a signature page of this Commitment Letter by facsimile or other electronic transmission shall be effective as
delivery of a manually executed counterpart hereof. Section headings used herein are for convenience of reference only, are not part of this Commitment Letter and are not to affect the construction of, or to be taken into consideration in
interpreting, this Commitment Letter. You acknowledge that information and documents relating to the Term Facility may be transmitted through SyndTrak, Intralinks, the internet, e-mail, or similar electronic transmission systems, and that none of us
shall be liable for any damages arising from the unauthorized use by others of information or documents transmitted in such manner, except to the extent such unauthorized use was found by a final, nonappealable judgment of a court of competent
jurisdiction to arise from our willful misconduct, bad faith or gross negligence. After the Closing Date, each Arranger may place customary advertisements in financial and other newspapers and periodicals or on a home page or similar place for
dissemination of information on the Internet or worldwide web as it may choose, and circulate similar promotional materials, after the closing of the Transactions in the form of a “tombstone” or otherwise describing the names of you, the
Borrower and your and its affiliates (or any of them), and the amount, type and closing date of such Transactions, all at such Arranger’s expense. This Commitment Letter and the Fee Letter supersede all prior understandings, whether written or
oral, between us with respect to the Term Facility. The obligations of the Initial Lenders and the Arrangers under this Commitment Letter, including the commitments of the Initial Lenders, shall be several and not joint. THIS COMMITMENT LETTER
SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK; PROVIDED, HOWEVER, THAT (A) THE DEFINITION OF “COMPANY MATERIAL ADVERSE EFFECT” (AS DEFINED HEREIN) AND THE INTERPRETATION OF
WHETHER OR NOT SUCH EVENT HAS OCCURRED, (B) THE DETERMINATION OF THE ACCURACY OF ANY MERGER AGREEMENT REPRESENTATION AND WHETHER AS A RESULT 

  
 9 

 
OF ANY INACCURACY THEREOF HOLDINGS OR THE BORROWER HAS THE RIGHT TO TERMINATE ITS OBLIGATIONS UNDER THE MERGER AGREEMENT OR TO DECLINE TO CONSUMMATE THE ACQUISITION AS A RESULT OF A BREACH OF
SUCH REPRESENTATIONS AND (C) THE DETERMINATION OF WHETHER THE ACQUISITION HAS BEEN CONSUMMATED IN ACCORDANCE WITH THE TERMS OF THE MERGER AGREEMENT, IN EACH CASE, SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAWS
OF THE STATE OF DELAWARE, REGARDLESS OF THE LAWS THAT MIGHT OTHERWISE GOVERN UNDER APPLICABLE PRINCIPLES OF CONFLICTS OF LAWS THEREOF. 
 10. Jurisdiction. 
 Each of the parties hereto hereby irrevocably and
unconditionally (a) submits, for itself and its property, to the exclusive jurisdiction of any New York State court or Federal court of the United States of America sitting in the Borough of Manhattan, and any appellate court from any thereof,
in any action or proceeding arising out of or relating to this Commitment Letter, the Fee Letter or the transactions contemplated hereby or thereby, and agrees that all claims in respect of any such action or proceeding may be heard and determined
only in such New York State court or, to the extent permitted by law, in such Federal court; provided that suit for the recognition or enforcement of any judgment obtained in any such New York State or Federal court may be brought in any
other court of competent jurisdiction, (b) waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating
to this Commitment Letter, the Fee Letter or the transactions contemplated hereby or thereby in any New York State court or in any such Federal court, (c) waives, to the fullest extent permitted by law, the defense of an inconvenient forum to
the maintenance of such action or proceeding in any such court, and (d) agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner
provided by law. Service of any process, summons, notice or document by registered mail addressed to you at the address above shall be effective service of process against you for any suit, action or proceeding brought in any such court. 

11. Waiver of Jury Trial. 
 EACH OF THE PARTIES HERETO IRREVOCABLY WAIVES THE RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING, CLAIM OR COUNTERCLAIM BROUGHT BY OR ON BEHALF OF ANY PARTY RELATED TO OR ARISING OUT OF THIS COMMITMENT
LETTER, THE FEE LETTER OR THE PERFORMANCE OF SERVICES HEREUNDER OR THEREUNDER. 

  
 10 

 12. Confidentiality. 

This Commitment Letter is delivered to you on the understanding that neither this Commitment Letter nor the Fee Letter nor any of their
terms or substance, nor our activities pursuant hereto, shall be disclosed, directly or indirectly, to any other person except (a) to your officers, directors, employees, attorneys, accountants and advisors on a confidential and need-to-know
basis, (b) as required by applicable law, rule or regulation or compulsory legal process (in which case you agree to inform us, to the extent legally permitted to do so, promptly thereof prior to such disclosure), (c) this Commitment
Letter and the existence and contents hereof (but not the Fee Letter or the contents thereof other than the existence thereof and the contents thereof as part of projections, pro forma information and a generic disclosure of aggregate sources and
uses to the extent customary in marketing materials and other disclosures) may be disclosed in any prospectus or offering memoranda relating to any offering of securities, in any syndication or other marketing material in connection with the Term
Facility or in connection with any public filing requirement, (d) the Term Sheet may be disclosed to potential Lenders and to any rating agency in connection with the Transactions, and (e) to the Company and the Seller and their respective
officers, directors, employees, attorneys, accountants and advisors on a confidential and need-to-know basis (provided that the Fee Letter and its terms and substance shall only be disclosed to the Seller and the Company and their respective
officers, directors, employees, attorneys, accountants, agents or advisors redacted in a manner satisfactory to the Arrangers). 

Notwithstanding anything herein to the contrary, any party to this Commitment Letter (and any employee, representative or other agent of
such party) may disclose to any and all persons, without limitation of any kind, the tax treatment and tax structure of the transactions contemplated by this Commitment Letter and the Fee Letter and all materials of any kind (including opinions or
other tax analyses) that are provided to it relating to such tax treatment and tax structure, except that (i) tax treatment and tax structure shall not include the identity of any existing or future party (or any affiliate of such party) to
this Commitment Letter or the Fee Letter and (ii) no party shall disclose any information relating to such tax treatment and tax structure to the extent nondisclosure is reasonably necessary in order to comply with applicable securities laws.
For this purpose, the tax treatment of the transactions contemplated by this Commitment Letter and the Fee Letter is the purported or claimed U.S. Federal income tax treatment of such transactions and the tax structure of such transactions is any
fact that may be relevant to understanding the purported or claimed U.S. Federal income tax treatment of such transactions. 

13. Surviving Provisions. 
 The compensation, reimbursement, indemnification, confidentiality, syndication, jurisdiction, governing law and waiver of jury trial provisions contained herein and in the Fee Letter and the provisions of
Section 8 hereof shall remain in full force and effect regardless of whether definitive financing documentation shall be executed and delivered 

  
 11 

 
and (other than in the case of the syndication provisions) notwithstanding the termination of this Commitment Letter or the Initial Lenders’ commitments hereunder and our agreements to
perform the services described herein. 
 14. PATRIOT Act Notification. 

We hereby notify you that, pursuant to the requirements of the USA PATRIOT Act, Title III of Pub. L. 107-56 (signed into law
October 26, 2001) (the “PATRIOT Act”), each of us and each Lender is required to obtain, verify and record information that identifies Holdings, the Borrower and the Subsidiary Guarantors, which information includes the
name, address, tax identification number and other information regarding Holdings, the Borrower and the Subsidiary Guarantors that will allow each of us or such Lender to identify Holdings, the Borrower and the Subsidiary Guarantors in accordance
with the PATRIOT Act. This notice is given in accordance with the requirements of the PATRIOT Act and is effective as to each of us and each Lender. You hereby acknowledge and agree that we shall be permitted to share any or all such information
with the Lenders. 
 15. Acceptance and Termination. 

If the foregoing correctly sets forth our agreement with you, please indicate your acceptance of the terms of this Commitment Letter and
of the Fee Letter by returning to us executed counterparts hereof and of the Fee Letter not later than 11:59 p.m., New York City time, on January 20, 2012. Each Initial Lender’s offer hereunder, and our agreements to perform the services
described herein, will expire automatically and without further action or notice and without further obligation to you at such time in the event that we have not received such executed counterparts in accordance with the immediately preceding
sentence. This Commitment Letter will become a binding commitment of each Initial Lender only after it has been duly executed and delivered by you in accordance with the first sentence of this Section 15. In the event that the Closing Date does
not occur on or before 5:00 p.m., New York City time, on April 20, 2012 (or such earlier date on which the Merger Agreement terminates or Holdings or the Borrower publicly announces its intention not to proceed with the Acquisition), then this
Commitment Letter and each Initial Lender’s commitment hereunder, and our agreements to perform the services described herein, shall automatically terminate without further action or notice and without further obligation to you unless each of
us shall, in our discretion, agree to an extension. 
 [Remainder of this page intentionally left blank] 

  
 12 

 We are pleased to have been given the opportunity to assist you in connection with the
financing for the Acquisition. 
  

			
	Very truly yours,
	
	CREDIT SUISSE SECURITIES (USA) LLC
		
	By	 	 /s/ Carly Baxter

		 	Name: Carly Baxter
		 	Title: Director
	
	 CREDIT SUISSE AG, CAYMAN
 ISLANDS BRANCH

		
	By	 	 /s/ Robert Hetu

		 	Name: Robert Hetu
		 	Title: Managing Director
		
	By	 	 /s/ Kevin Buddhdew

		 	Name: Kevin Buddhdew
		 	Title: Associate

  

[TRANSDIGM COMMITMENT LETTER] 

 
			
	UBS SECURITIES LLC
		
	By	 	 /s/ Ryan Vetsch

		 	Name: Ryan Vetsch
		 	Title: Director
		
	By	 	 /s/ Barbara S. Wang

		 	Name: Barbara S. Wang
		 	 Title:  Director and Counsel
            Region Americas Legal

	
	UBS LOAN FINANCE LLC
		
	By	 	 /s/ Ryan Vetsch

		 	Name: Ryan Vetsch
		 	Title: Director
		
	By	 	 /s/ Barbara S. Wang

		 	Name: Barbara S. Wang
		 	 Title:  Director and Counsel
            Region Americas Legal

  

[TRANSDIGM COMMITMENT LETTER] 

			
	Accepted and agreed to as of
	the date first above written:
	
	TRANSDIGM GROUP INCORPORATED
		
	By	 	 /s/ Gregory Rufus

		 	Name:
		 	Title:

			
	CONFIDENTIAL	 	
	January 20, 2012	 	EXHIBIT A

 $500,000,000 Senior Secured Term Facility 

Summary of Principal Terms and Conditions 
  

			
	Borrower:	  	Transdigm Inc., a Delaware corporation (the “Borrower”), all of the outstanding equity interests of which are owned by Transdigm Group Incorporated, a Delaware
corporation (“Holdings”).
		
	Transactions:	  	The Borrower intends to acquire (the “Acquisition”) all of the equity interests of AmSafe Global Holdings, Inc., a Delaware corporation (the
“Company”) from BSR LLC, Greenbriar Equity Fund II, L.P. and related investors (collectively referred to herein as the “Seller”) pursuant to an agreement and plan of merger (including the schedules and
exhibits thereto, the “Merger Agreement”) to be entered into among the Seller, the Borrower, AGH Acquisition, Inc., a Delaware corporation (“Merger Sub”), all the outstanding equity interests of which
will be owned by the Borrower, and the Seller. In connection with the Acquisition, (a) Merger Sub will be merged with and into the Company on the terms and conditions set forth in the Merger Agreement with the Company surviving as a wholly
owned subsidiary of the Borrower, (b) the Borrower will obtain the senior secured term loan facility described below under the caption “Senior Secured Term Facility”, (c) the Company will repay in full, and discharge, certain existing
indebtedness (the “Company Existing Debt”), and (d) fees and expenses incurred in connection with the foregoing (the “Transaction Costs”) will be paid. The transactions described in this paragraph
are collectively referred to herein as the “Transactions”.
		
	Agent:	  	Credit Suisse AG, acting through one or more of its branches or affiliates (“CS”), will act as sole administrative agent and collateral agent
(collectively, in such capacities, the “Agent”) for a syndicate of banks, financial institutions and other institutional lenders (together with CS, the “Lenders”), and will perform the duties
customarily

			
		  	associated with such roles.
		
	 Joint Lead Arrangers
 and Joint Bookrunners:
	  	Credit Suisse Securities (USA) LLC and UBS Securities LLC will act as joint lead arrangers and joint bookrunners for the Term Facility described below (collectively, in such
capacities, the “Arrangers”), and will perform the duties customarily associated with such roles.
		
	Syndication Agent:	  	UBS Securities LLC will act as syndication agent for the Term Facility (in such capacity, the “Syndication Agent”).
		
	Documentation Agent:	  	At the option of the Arrangers, one or more financial institutions identified by the Arrangers and acceptable to the Borrower (in such capacity, the “Documentation
Agent”).
		
	 Senior Secured Term

Facility:
	  	A senior secured term loan facility in an aggregate principal amount of up to $500,000,000 (the “Term Facility”).
		
	 Incremental Term

Facility:
	  	The Borrower shall be entitled on one or more occasions and subject to satisfaction of customary conditions to incur additional term loans under the Term Facility or under a new
term loan facility (such term loans, the “Additional Term Loans”), with such Additional Term Loans having the same guarantees as, and being secured on a pari passu basis by, the same collateral securing the Term
Facility; provided that the aggregate principal amount of all such Additional Term Loans plus the aggregate amount of all incremental term facilities and incremental revolving facilities incurred under the Existing Credit Agreements shall in
no event exceed $500,000,000; provided further that (i) no event of default or default exists or would exist after giving effect thereto, (ii) the Borrower’s ratio of senior secured debt to EBITDA would not exceed 4.00:1.00, each on a
pro forma basis on the date of incurrence and for the most recent determination period, after giving effect to any such Additional Term Loans and other customary and appropriate pro forma adjustment events, (iii) the maturity date of the Additional
Term Loans shall be no earlier than the maturity date of the Term Facility, (iv) the average life to maturity of the

  
 A-2

			
		  	Additional Term Loans shall be no shorter than the remaining average life to maturity of the Term Facility, (v) the Additional Term Loans shall be subject to a “most favored
nation” pricing provision that ensures that the initial yield on the Additional Term Loans does not exceed the yield on the Term Facility by more than 50 basis points (in each case taking into account any applicable original issue discount,
upfront fee, applicable margins and LIBOR “floor”) and (vi) the other terms and documentation in respect thereof, to the extent not consistent with the Term Facility, shall otherwise be reasonably satisfactory to the Agent. The Borrower
may seek commitments in respect of Additional Term Loans from existing Lenders (each of which shall be entitled to agree or decline to participate in its sole discretion) and additional banks, financial institutions and other institutional lenders
who will become Lenders in connection therewith.
		
	Purpose:	  	The proceeds of the Term Facility will be used by the Borrower, on the date of the initial borrowing thereunder (the “Closing Date”), together with cash
on hand at the Borrower, solely (a) to pay the cash consideration contemplated pursuant to the Merger Agreement, (b) to refinance the Company Existing Debt and (c) to pay the Transaction Costs.
		
	Availability:	  	The full amount of the Term Facility (other than, for the avoidance of doubt, any Additional Term Loans) must be drawn in a single drawing on the Closing Date. Amounts borrowed
under the Term Facility that are repaid or prepaid may not be reborrowed.
		
	 Original Issue

Discount:
	  	The Term Facility will be funded with 100 basis points of original issue discount.
		
	Interest Rates and Fees:	  	As set forth on Annex I hereto.
		
	Default Rate:	  	The applicable interest rate plus 2.0% per annum upon the occurrence and during the continuance of a payment or bankruptcy event of default at the option of the required
lenders.
		
	 Final Maturity

and Amortization:
	  	The Term Facility will mature on February 14, 2017, and will amortize in equal quarterly installments in an aggregate annual amount equal to 1% of
the

  
 A-3

			
		  	original principal amount of the Term Facility with the balance payable on the maturity date of the Term Facility.
		
	Guarantees:	  	All obligations of the Borrower under the Term Facility will be unconditionally guaranteed (the “Guarantees”) by Holdings and by each existing and
subsequently acquired or organized domestic and, to the extent no adverse tax consequences to the Borrower would result therefrom, foreign subsidiary of the Borrower (the “Subsidiary Guarantors”); provided, however
that no unrestricted subsidiary (to be defined in a manner consistent with the Existing Credit Agreements (defined below)) will be or become a Subsidiary Guarantor. Notwithstanding anything to the contrary contained herein, the requirement of
this paragraph shall be, as of the Closing Date, subject to the Conditions Limitation Provision of the Commitment Letter.
		
	Security:	  	The Term Facility and the Guarantees will be secured by all of the assets of Holdings, the Borrower and each Subsidiary Guarantor, whether owned on the Closing Date or thereafter
acquired, that secure the obligations under the credit agreement dated as of February 14, 2011 (the “2011 Credit Agreement”), among the Borrower, Holdings, each subsidiary of the Borrower from time to time party thereto, the
lenders from time to time party thereto and CS, as administrative agent and collateral agent and the credit agreement dated as of December 6, 2010 (the “2010 Credit Agreement” and, together with the 2011 Credit Agreement, the
“Existing Credit Agreements”), among the Borrower, Holdings, each subsidiary of the Borrower from time to time party thereto, the lenders from time to time party thereto and CS, as administrative agent and collateral agent
(collectively, the “Collateral”).
		
		  	The security interests in the Collateral shall be created pursuant to amendments to the Collateral Documents (as defined in the Existing Credit Agreements), as contemplated by
Section 9.02(b) of each Existing Credit Agreement, and none of the Collateral shall be subject to any other liens, other than the pari passu liens securing indebtedness
under

  
 A-4

			
		  	the Existing Credit Agreements, permitted liens (to be defined in a manner consistent with the Existing Credit Agreements) and subject to other customary and limited exceptions
to be agreed upon.
		
		  	Notwithstanding anything to the contrary contained herein, the requirements of the two preceding paragraphs shall be, as of the Closing Date, subject to the Conditions Limitation
Provision of the Commitment Letter.
		
	 Mandatory

Prepayments:
	  	Loans under the Term Facility shall be prepaid with (a) if greater than zero, the sum of 50% of Excess Cash Flow (to be defined) minus the aggregate amount of such Excess
Cash Flow that is required to be applied to the prepayment of term loans under the 2011 Credit Agreement, with reductions to be agreed upon based upon achievement and maintenance of leverage ratios to be agreed upon, (b) 100% of the net cash
proceeds of all asset sales or other dispositions of property by Holdings and its subsidiaries (including proceeds from the sale of stock of any subsidiary of the Borrower and insurance and condemnation proceeds) (subject to reinvestment provisions
and other exceptions to be agreed upon) and (c) 100% of the net cash proceeds of issuances, offerings or placements of debt obligations of Holdings and its subsidiaries (subject to exceptions to be agreed upon).
		
		  	The above described mandatory prepayments shall be applied pro rata to the remaining amortization payments under the Term Facility.
		
	Voluntary Prepayments:	  	Prepayments of loans under the Term Facility will be permitted at any time, in minimum principal amounts to be agreed upon, without premium or penalty, subject to reimbursement
of the Lenders’ redeployment costs in the case of a prepayment of Adjusted LIBOR borrowings other than on the last day of the relevant interest period, except that any Repricing Payment (as defined below) made to any Lender under the Term
Facility prior to the first anniversary of the Closing Date shall be accompanied by a premium of 1.0% of such Repricing Payment. As used herein, a “Repricing Payment” is the
amount

  
 A-5

			
		  	of principal of the loan of a Lender under the Term Facility that is either (i) prepaid by the Borrower substantially concurrently with the incurrence by Holdings, the Borrower
or any of its subsidiaries of new indebtedness that has an effective yield (to be determined in the reasonable discretion of the Agent consistent with generally accepted financial practices, after giving effect to margin and any applicable LIBOR
“floors”, upfront or similar fees or original issue discount shared with all lenders or holders thereof, but excluding the effect of any arrangement, structuring, syndication or other fees payable in connection therewith that are not
shared with all lenders or holders thereof) lower than the yield then in effect for the loans under the Term Facility so prepaid or (ii) received by such Lender (other than as a Repricing Payment described in clause (i)) as a result of the
mandatory assignment of such loans following the failure of such Lender to consent to an amendment of the Term Facility that becomes effective and has the effect of reducing the effective interest rate with respect to the loans under the Term
Facility.
		
		  	All voluntary prepayments of the Term Facility will be applied to the remaining amortization payments under the Term Facility as directed by the Borrower.
		
	 Representations and

Warranties:
	  	The same as in the 2011 Credit Agreement, namely corporate status, power and authorization; legal, valid and binding documentation; no governmental consents; accuracy in all
material respects of financial statements, confidential information memorandum and other information; no material adverse change; subsidiaries; absence of undisclosed liabilities, litigation and investigations; no violation of, or conflicts with,
agreements or instruments; compliance with laws (including the PATRIOT Act, ERISA, margin regulations, environmental laws and laws applicable to sanctioned persons and the Foreign Corrupt Practices Act); payment of taxes; ownership of properties;
intellectual property; inapplicability of the Investment Company Act; solvency on a consolidated basis; effectiveness of governmental approvals; labor matters; insurance;
environmental

  
 A-6

			
		  	and other regulatory matters; status of the Term Facility and guarantees thereof as “senior debt” and “designated senior debt”; and validity, priority and
perfection of security interests in the Collateral.
		
	 Conditions Precedent to
 Borrowing:
	  	The availability of the Term Facility on the Closing Date will be subject only to (a) the conditions precedent set forth in Section 6 of the Commitment Letter and listed on
Exhibit B attached to the Commitment Letter, (b) the delivery of prior written notice of borrowing, (c) the accuracy in all material respects (and in all respects if qualified by materiality) of the representations and warranties (subject to
the Conditions Limitation Provision) and (d) the absence of defaults (other than a default arising as a result of a breached representation and warranty made on the Closing Date, which is covered by the immediately preceding condition and
subject to the Conditions Limitation Provision).
		
	Affirmative Covenants:	  	The same as in the 2011 Credit Agreement, namely maintenance of corporate existence and rights; performance of obligations; delivery of consolidated financial statements and
other information, including information required under the PATRIOT Act; delivery of notices of default, litigation, ERISA events and material adverse change; maintenance of properties in good working order; maintenance of satisfactory insurance;
use of commercially reasonable efforts to maintain a public rating of the Term Facility from each of Standard & Poor’s Ratings Service (“S&P”) and Moody’s Investors Service, Inc.
(“Moody’s”); compliance with laws; inspection of books and properties; use of proceeds; further assurances; and payment of taxes.
		
	Negative Covenants:	  	The same as in the 2011 Credit Agreement, namely limitations on dividends on, and redemptions and repurchases of, equity interests and other restricted payments; limitations on
prepayments, redemptions and repurchases of subordinated debt; limitations on liens and sale-leaseback transactions; limitations on loans and investments; limitations on debt, guarantees and hedging arrangements; limitations on mergers and
acquisitions; limitations on asset sales;

  
 A-7

			
		  	limitations on transactions with affiliates; limitations on changes in business conducted by the Borrower and its subsidiaries (and prohibition of Holdings engaging in business
activities or incurring liabilities other than its ownership of the equity interests of the Borrower and activities and liabilities incidental thereto, including its guarantee of the Term Facility and of the obligations under the Existing Credit
Agreements); limitations on restrictions on ability of subsidiaries to pay dividends or make distributions; limitations on impairment of security interest; and limitations on amendments of debt and other material agreements.
		
	 Financial Maintenance

Covenants:
	  	None.
		
	Events of Default:	  	The same as in the 2011 Credit Agreement, relating to Holdings and its subsidiaries (subject to thresholds and grace periods as set forth in the 2011 Credit Agreement), namely
nonpayment of principal, interest or other amounts; violation of covenants; incorrectness of representations and warranties in any material respect; cross-default and cross-acceleration; bankruptcy; material judgments; ERISA events; actual or
asserted invalidity of guarantees or security documents; actual or asserted invalidity of subordination provisions; and Change of Control (as defined in the 2011 Credit Agreement).
		
	Voting:	  	The same as in the 2011 Credit Agreement.
		
	 Cost and Yield

Protection:
	  	Usual for facilities and transactions of this type, including customary tax gross-up provisions (including, without limitation, with respect to the Dodd-Frank Wall Street Reform
and Consumer Protection Act and Basel III).
		
	Assignments and Participations:	  	The Lenders will be permitted to assign loans under the Term Facility without the consent of (but with notice to) the Borrower. All assignments will be by novation and will
require the consent of the Agent, not to be unreasonably withheld or delayed. Each assignment will be in a minimum amount of $1,000,000.

  
 A-8

			
		
		  	The Lenders will be permitted to sell participations in loans and commitments without restriction. Voting rights of participants shall be limited to matters in respect of
(a) increases in commitments of such participant, (b) reductions of principal, interest or fees payable to such participant, (c) extensions of final maturity or scheduled amortization of the loans in which such participant
participates and (d) releases of all or substantially all of the value of the Guarantees, or all or substantially all of the Collateral.
		
	 Expenses and

Indemnification:
	  	The Borrower will indemnify the Arrangers, the Agent, the Syndication Agent, the Documentation Agent, the Lenders, their respective affiliates, successors and assigns and the
partners, officers, directors, employees, agents, advisors, controlling persons and members of each of the foregoing (each, an “Indemnified Person”) and hold them harmless from and against all costs, expenses (including
reasonable fees, disbursements and other charges of counsel) and liabilities of such Indemnified Person arising out of or relating to any claim or any litigation or other proceeding (regardless of whether such Indemnified Person is a party thereto
and regardless of whether such matter is initiated by a third party or by Holdings, the Borrower, the Company or any of their respective affiliates or shareholders) that relates to the Transactions, including the financing contemplated hereby, the
Acquisition or any transactions in connection therewith; provided that no Indemnified Person will be indemnified for any cost, expense or liability to the extent they are found by a final, nonappealable judgment of a court of competent
jurisdiction to arise from the willful misconduct, bad faith or gross negligence of such Indemnified Person. In addition, all reasonable out-of-pocket expenses (including, without limitation, reasonable fees, disbursements and other charges of a
single counsel plus, to the extent necessary, one local counsel in each applicable jurisdiction and any special counsel and, in the case of a conflict of interest or separate defenses available to Indemnified Persons that are different from those
available to the other Indemnified Persons, one additional counsel per

  
 A-9

			
		  	affected party) of the Arrangers, the Agent, the Syndication Agent, the Documentation Agent and the Lenders associated with the pre-closing syndication of the Term Facility and
with the preparation, execution and delivery, administration, waiver or modification and enforcement of the Loan Documents, and other documentation contemplated hereby and thereby, and for enforcement costs and documentary taxes associated with the
Term Facility will be paid by the Borrower.
		
	Governing Law and Forum:	  	New York.
		
	 Counsel to the Agent

and the Arrangers:
	  	Cravath, Swaine & Moore LLP.

  
 A-10

 ANNEX I 
  

			
	Interest Rate:	  	The interest rate under the Term Facility will be, at the option of the Borrower, Adjusted LIBOR plus 3.50% or ABR plus 2.50%.
		
		  	The Borrower may elect interest periods of 1, 2, 3 or 6 months for Adjusted LIBOR borrowings.
		
		  	Calculation of interest shall be on the basis of the actual days elapsed in a year of 360 days (or 365 or 366 days, as the case may be, in the case of ABR loans based on the
Prime Rate) and interest shall be payable at the end of each interest period and, in any event, at least every three months.
		
		  	ABR is the Alternate Base Rate, which is the highest of (i) CS’s Prime Rate, (ii) the Federal Funds Effective Rate plus  1/2 of 1.0% and (iii) the Adjusted LIBOR for a three-month interest
period plus 1.00%.
		
		  	Adjusted LIBOR will at all times include statutory reserves and shall be deemed to be not less than 1.00% per annum.

			
	 CONFIDENTIAL
	 	
	January 20, 2012	 	EXHIBIT B

 $500,000,000 Senior Secured Term Facility 

Summary of Additional Conditions Precedent1 
 Subject in all respects to the Conditions Limitation Provision, the borrowing under the Term Facility shall be subject to the following additional conditions precedent: 

1.    The Acquisition and the other Transactions shall be consummated simultaneously with the closing under the Term
Facility in accordance with, and on the terms described in the Merger Agreement, without giving effect to any material amendment, waiver or other modification thereof, or material consent thereunder, that would be adverse in any material respect to
the Lenders or either Arranger, unless approved in writing by the Arrangers, which approval may not be unreasonably withheld or delayed. 
 2.    All amounts due or outstanding in respect of the Company Existing Debt shall have been (or substantially simultaneously with the closing under the Term Facility shall be) paid in
full, all commitments (if any) in respect thereof terminated and all guarantees (if any) thereof and security (if any) therefor discharged and released. After giving effect to the Transactions and the other transactions contemplated hereby, Holdings
and its subsidiaries shall have outstanding no indebtedness or preferred stock other than (a) the loans and other extensions of credit under the Term Facility, (b) indebtedness under the Existing Credit Agreements and the 7 3/4% Senior
Subordinated Notes due 2018 issued by the Borrower and (c) other limited indebtedness to be agreed upon. 

3.    The Agent shall have received (a) U.S. GAAP audited consolidated balance sheets and related statements of
income, stockholders’ equity and cash flows of each of Holdings and the Company for the 2009, 2010 and 2011 fiscal years, in the case of Holdings, and the 2008, 2009 and 2010 fiscal years, in the case of the Company (and the Agent acknowledges
receipt of the foregoing) and (b) U.S. GAAP unaudited consolidated balance sheets and related statements of income, stockholders’ equity and cash flows of each of Holdings and the Company for each subsequent fiscal quarter ended 45
days before the Closing Date. 
 4.    The Agent shall have received a pro forma consolidated balance sheet
and related pro forma consolidated statements of income and cash flows of the Borrower as of and for the twelve-month period ending on the last day of the most recently completed four-fiscal quarter period for which financial statements have been
delivered pursuant to paragraph 3 above, prepared after giving effect to the Transactions as if the Transactions had occurred as of such date (in the case of such balance sheet) or at the beginning of such period (in the case of such other financial
statements). 
  

	1 	All capitalized terms used but not defined herein have the meanings given to them in the Commitment Letter to which this Exhibit B is attached, including Exhibit A
thereto. 

 5.    The Arrangers shall have received a certificate from the chief
financial officer of Holdings, in form and substance satisfactory to the Arrangers (it being understood that the form of such certificate shall be substantially as attached hereto as Annex I), certifying that Holdings and its subsidiaries, on a
consolidated basis after giving effect to the Transactions and the other transactions contemplated hereby, are solvent. 

6.    The Arrangers shall have received, at least five business days prior to the Closing Date, all documentation and
other information required by regulatory authorities under applicable “know your customer” and anti-money laundering rules and regulations, including, without limitation, the PATRIOT Act that is requested by either Arranger, the Agent or
any Lender at least 10 days prior to the Closing Date. 
 7.    The Arrangers shall have received customary
legal opinions, corporate documents, officers’ and public officials’ certifications, results of lien and judgment searches, evidence of authority and certificates of insurance (including a customary insurance broker’s letter or
endorsement), in each case in form and substance reasonably satisfactory to the Arrangers. 
 8.    The
Guarantees shall be in full force and effect and all actions necessary to establish that the Agent will have perfected first-priority security interests in the Collateral (free and clear of all liens, other than the pari passu liens securing
indebtedness under the Existing Credit Agreements and permitted liens (to be defined in a manner consistent with the 2011 Credit Agreement), subject to customary and limited exceptions to be agreed upon) shall have been taken. 

  
 2 

 ANNEX I 
 SOLVENCY CERTIFICATE 
 TRANSDIGM GROUP INCORPORATED 

THIS SOLVENCY CERTIFICATE (this “Certificate”) is delivered in connection with, and pursuant to
Section [—] of, the Credit Agreement dated as of [—], 2012 (the “Credit Agreement”), among TransDigm Inc., a Delaware
corporation (the “Borrower”), TransDigm Group Incorporated, a Delaware corporation (“Holdings”), the subsidiaries of the Borrower from time to time party thereto, various financial institutions as
Lenders (the “Lenders”), and Credit Suisse, as Administrative Agent and Collateral Agent. Capitalized terms used herein and not defined shall have the meanings attributed to them in the Credit Agreement. 

The undersigned Financial Officer of Holdings hereby certifies on behalf of Holdings, the Borrower and its Subsidiaries, in his
corporate capacity as Chief Financial Officer and not his individual capacity, to the solvency of Holdings, the Borrower and its Subsidiaries on consolidated basis after giving effect to the consummation of the Acquisition and other Transactions
contemplated to occur on the Closing Date and further certifies as follows. 
  

	 	1.	The undersigned, [—], is the duly qualified and acting Chief Financial Officer of Holdings and in such capacity is the
senior financial officer of Holdings and has the responsibility for the management of Holdings’s financial affairs. The undersigned is familiar with Holdings’s and its Subsidiaries’ financial and accounting matters and the terms and
conditions of the financings proposed to be arranged pursuant to the Credit Agreement and the Acquisition and the other Transactions proposed to be consummated on the Closing Date. 

 

	 	2.	The undersigned has carefully reviewed the contents of this Certificate and all other information and documentation that the undersigned has determined is reasonably
necessary to make the statements contained in this Certificate. The statements made herein are made in good faith and are based upon the personal knowledge of the undersigned, or upon reports and other information given to the undersigned by
supervisory personnel of Holdings and its Subsidiaries having responsibility for the reports and the information given, and who, in the opinion of the undersigned, are reliable and entitled to be relied upon. 

Based on the foregoing, the undersigned hereby certifies that immediately after giving effect to the consummation of the Acquisition and
other Transactions contemplated to occur on the Closing Date: 

	 	1.	The fair value of the assets of Holdings, the Borrower and each Guarantor (the “Loan Parties”) on a consolidated basis, at fair valuation, will
exceed the debts and liabilities, direct, subordinated, contingent or otherwise, of the Loan Parties on a consolidated basis. 

  

	 	2.	The present fair saleable value of the property of the Loan Parties on a consolidated basis will be greater than the amount that will be required to pay the probable
liability of the Loan Parties on a consolidated basis on their debts and other liabilities, direct, subordinated, contingent or otherwise, as such debts and other liabilities become absolute and matured. 

 

	 	3.	The Loan Parties on a consolidated basis will be able to pay their debts and liabilities, direct, subordinated, contingent or otherwise, as such debts and liabilities
become absolute and matured. 

  

	 	4.	The Loan Parties on a consolidated basis will not have unreasonably small capital with which to conduct the businesses in which they are engaged as such businesses are
now conducted and are proposed to be conducted following the date hereof . 

 For purposes of this Certificate,
the amount of any contingent liability has been computed as the amount that, in light of all of the facts and circumstances existing as of the date hereof, represents the amount that can reasonably be expected to become an actual or matured
liability. The undersigned understands that the Lenders and the Agent are relying upon the foregoing statements in this Certificate in connection with the consummation of the Acquisitions and the other Transactions. 

Executed as of [—], 2012. 

 

	
	  

	Name: [—]
	Title: Chief Financial Officer

  
 2 

			
	 CONFIDENTIAL
	 	
	 January 20, 2012
	 	EXHIBIT C

 $500,000,000 Senior Secured Term Facility 

Definition of Company Material Adverse Effect 
 For purposes of the Commitment Letter, “Company Material Adverse Effect” shall be defined as follows: 
 “Company Material Adverse Effect” means any effect, change, event, occurrence, development or circumstance (any such item, an “Effect”) that, individually or in
the aggregate, is or would reasonably be expected to have a material adverse effect on or change in the financial condition, liabilities, business or results of operations of the Company and the Subsidiaries (as defined in the Merger Agreement),
taken as a whole; provided, however, that no Effect caused by or resulting from any of the following, either alone or in combination, shall constitute or be taken into account in determining whether there has been or will be a
“Company Material Adverse Effect”: (a) any Effect affecting the economy of the United States generally, including changes in the credit, debt, capital or financial markets (including changes in interest or exchange rates) or
the economy of any region or country in which the Company or any Subsidiaries conducts business; (b) any Effect affecting the industries in which the Company and the Subsidiaries operate; (c) any Effect arising in connection with global,
national or regional political conditions, including hostilities, military actions, political instability, acts of terrorism or war or any escalation or material worsening of any such hostilities, military actions, political instability, acts of
terrorism or war existing or underway as of the date of the Merger Agreement; (d) any failure, in and of itself, by the Company or any Subsidiary to meet any internal or published projections, forecasts or revenue or earnings predictions for
any period ending on or after the date of the Merger Agreement (it being understood that the facts or occurrences giving rise to such failure may be deemed to constitute, or be taken into account in determining whether there has been or will be, a
Company Material Adverse Effect); (e) compliance with, or any action required to be taken by the Company or any Subsidiary under the terms of the Merger Agreement; (f) any Effect that results from any action taken at the express prior
request of Buyer (as defined in the Merger Agreement) or with Buyer’s prior consent, in each case with the approval of the Arrangers (not to be unreasonably withheld or delayed); (g) the announcement of the execution of the Merger
Agreement, or the pendency of the Transactions (as defined in the Merger Agreement), including the effects of the Transactions (as defined in the Merger Agreement) on relationships with suppliers, Governmental Bodies (as defined in the Merger
Agreement), employees, or other third-party relationships; (h) any change in Law (as defined in the Merger Agreement) or GAAP (as defined in the Merger Agreement) or interpretation thereof; (i) any breach by Buyer or Merger Sub of their
obligations under the Merger Agreement; or (j) any change in budget or appropriations policies or amounts of any Governmental Body, unless, in the cases of clauses (a), (b), (c), (h) or (j) above, such changes would reasonably be

 
expected to have a materially disproportionate impact on the financial condition, liabilities, business or results of operations of the Company and the Subsidiaries, taken as a whole, relative to
other affected participants in the industries in which the Company and the Subsidiaries operate (in which case, only the incremental disproportionate impact shall be taken into account in determining whether there has been a Company Material Adverse
Effect). 

  
 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00204-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00204-of-00352.parquet"}]]